Role of scavenger receptors in glia-mediated neuroinflammatory response associated with Alzheimer's disease

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Cornejo, Francisca ^a   Von Bernhardi, Rommy ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CD36 ANTIGEN; CD68 ANTIGEN; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NEUROTOXIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR A; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; AMYLOID BETA PROTEIN; SCAVENGER RECEPTOR;

AGING; ALZHEIMER DISEASE; ASTROCYTE; CELL DIFFERENTIATION; CHEMOTAXIS; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; DRUG TARGETING; GLIA; GLIA CELL; HIPPOCAMPUS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MICROGLIA; MONOCYTE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; GENETICS; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; HUMANS; NEUROGLIA; RECEPTORS, SCAVENGER;

EID: 84878630403     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/895651     Document Type: Review

References (135)

1. Lobo A., Launer L. J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M. M. B., Copeland J. R. M., Dartigues J. F., Jagger C., Martinez-Lage J., Soininen H., Hofman A., Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000 54 supplement 11 S4 S9 2-s2.0-0034643928 (Pubitemid 30390598)
2. Mayeux R., Stern Y., Epidemiology of Alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2012 2 8 1 18
3. von Bernhardi R., Eugenin J., Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxidants and Redox Signaling 2012 16 974 1031
4. Hardy J. A., Higgins G. A., Alzheimer's disease: the amyloid cascade hypothesis. Science 1992 256 5054 184 185 2-s2.0-0026597063
5. Aisen P. S., Davis K. L., Inflammatory mechanisms in Alzheimer's disease: implications for therapy. American Journal of Psychiatry 1994 151 8 1105 1113 2-s2.0-0028103819 (Pubitemid 24240950)
6. von Bernhardi R., Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotoxicity Research 2007 12 4 215 232 2-s2.0-41749116202 10.1007/BF03033906
7. Qiu C., Kivipelto M., von Strauss E., Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues in Clinical Neuroscience 2009 11 2 111 128 2-s2.0-67650844275
8. Mattsson M. O., Simko M., Is there a relation between extremely low frequency magnetic field exposure, inflammation and neurodegenerative diseases? A review of in vivo and in vitro experimental evidence. Toxicology 2012 301 1 12
9. von Bernhardi R., Tichauer J. E., Eugenín J., Aging-dependent changes of microGlial cells and their relevance for neurodegenerative disorders. Journal of Neurochemistry 2010 112 5 1099 1114 2-s2.0-75949127404 10.1111/j.1471-4159.2009.06537.x
10. Solito E., Sastre M., MicroGlia function in Alzheimer's disease. Frontiers in Pharmacology 2012 3, article 14
11. Paresce D. M., Ghosh R. N., Maxfield F. R., MicroGlial cells internalize aggregates of the Alzheimer's disease amyloid β -protein via a scavenger receptor. Neuron 1996 17 3 553 565 2-s2.0-0030248270 10.1016/S0896-6273(00) 80187-7 (Pubitemid 26322226)
12. von Bernhardi R., Ramírez G., Toro R., Eugenín J., Pro-inflammatory conditions promote neuronal damage mediated by Amyloid Precursor Protein and decrease its phagocytosis and degradation by microGlial cells in culture. Neurobiology of Disease 2007 26 1 153 164 2-s2.0-33947234997 10.1016/j.nbd.2006.12.006 (Pubitemid 46436495)
13. Ramírez G., Rey S., von Bernhardi R., Proinflammatory stimuli are needed for induction of microGlial cell-mediated A β PP-{244-C} and A β -neurotoxicity in hippocampal cultures. Journal of Alzheimer's Disease 2008 15 1 45 59 2-s2.0-52449104934
14. Harry G. J., Kraft A. D., Neuroinflammation and microGlia: considerations and approaches for neurotoxicity assessment. Expert Opinion on Drug Metabolism and Toxicology 2008 4 10 1265 1277 2-s2.0-55049136520 10.1517/17425255.4.10.1265
15. Luo X. G., Ding J. Q., Chen S. D., MicroGlia in the aging brain: relevance to neurodegeneration. Molecular Neurodegeneration 2010 5 1, article 12 2-s2.0-77950826971 10.1186/1750-1326-5-12
16. Rogers J., Luber-Narod J., Styren S. D., Civin W. H., Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiology of Aging 1988 9 4 339 349 2-s2.0-0024157709 (Pubitemid 19262065)
17. Combs C. K., Colleen Karlo J., Kao S. C., Landreth G. E., β -amyloid stimulation of microGlia anti monocytes results in TNF α -dependent expression of inducible nitric oxide synthase and neuronal apoptosis. The Journal of Neuroscience 2001 21 4 1179 1188 2-s2.0-0035866060 (Pubitemid 32128763)
18. Yasojima K., Schwab C., McGeer E. G., McGeer P. L., Up-regulated production and activation of the complement system in Alzheimer's disease brain. American Journal of Pathology 1999 154 3 927 936 2-s2.0-0033061855 (Pubitemid 29122612)
19. Strauss S., Bauer J., Ganter U., Jonas U., Berger M., Volk B., Detection of interleukin-6 and α 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Laboratory Investigation 1992 66 2 223 230 2-s2.0-0026553710
20. Ishizuka K., Kimura T., Igata-Yi R., Katsuragi S., Takamatsu J., Miyakawa T., Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microGlia of Alzheimer's disease. Psychiatry and Clinical Neurosciences 1997 51 3 135 138 2-s2.0-0030988629 (Pubitemid 27262094)
21. Del Bo R., Angeretti N., Lucca E., de Simoni M. G., Forloni G., Reciprocal control of inflammatory cytokines, IL-1 and IL-6, β -amyloid production in cultures. Neuroscience Letters 1995 188 1 70 74 2-s2.0-0028946146 10.1016/0304-3940(95)11384-9
22. Lue L. F., Rydel R., Brigham E. F., Yang L. B., Hampel H., Murphy G. M., Brachova L., Yan S. D., Walker D. G., Shen Y., Rogers J., Inflammatory repertoire of Alzheimer's disease and nondemented elderly microGlia in vitro. Glia 2001 35 1 72 79 2-s2.0-0034948192 10.1002/Glia.1072 (Pubitemid 32656755)
23. Murgas P., Godoy B., von Bernhardi R., Abeta potentiates inflammatory activation of Glial cells induced by scavenger receptor ligands and inflammatory mediators in culture. Neurotoxicity Research 2012 22 69 78
24. Lindberg C., Selenica M. L. B., Westlind-Danielsson A., Schultzberg M., β -amyloid protein structure determines the nature of cytokine release from rat microGlia. Journal of Molecular Neuroscience 2005 27 1 1 12 2-s2.0-23444455475 10.1385/JMN:27:01:01 (Pubitemid 41112374)
25. Dickson D. W., Farlo J., Davies P., Crystal H., Fuld P., Yen S. H. C., Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. American Journal of Pathology 1988 132 1 86 101 2-s2.0-0023809230
26. Barger S. W., Harmon A. D., MicroGlial activation by alzhelmer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997 388 6645 878 881 2-s2.0-0030610645 10.1038/42257 (Pubitemid 27377060)
27. Flores B., von Bernhardi R., Transforming growth factor beta1 modulates amyloid beta-induced Glial activation through the Smad3-dependent induction of MAPK phosphatase-1. Journal of Alzheimer's Disease 2012 32 417 429
28. Simard A. R., Soulet D., Gowing G., Julien J. P., Rivest S., Bone marrow-derived microGlia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006 49 4 489 502 2-s2.0-32344440522 10.1016/j.neuron.2006.01.022 (Pubitemid 43221886)
29. Floden A. M., Combs C. K., β -amyloid stimulates murine postnatal and adult microGlia cultures in a unique manner. The Journal of Neuroscience 2006 26 17 4644 4648 2-s2.0-33646841989 10.1523/JNEUROSCI.4822-05.2006 (Pubitemid 44315365)
30. von Bernhardi R., Tichauer J., Eugenin-von Bernhardi L., Proliferating culture of aged microGlia for the study of neurodegenerative diseases. Journal of Neuroscience Methods 2011 202 65 69
31. Geula C., Wu C. K., Saroff D., Lorenzo A., Yuan M., Yankner B. A., Aging renders the brain vulnerable to 26 β -protein neurotoxicity. Nature Medicine 1998 4 7 827 831 2-s2.0-0031824782 10.1038/nm0798-827 (Pubitemid 28331025)
32. Barron K. D., The microGlial cell. A historical review. Journal of the Neurological Sciences 1995 134 supplement 1 57 68 2-s2.0-0029434439 10.1016/0022-510X(95)00209-K
33. Napoli I., Neumann H., Protective effects of microGlia in multiple sclerosis. Experimental Neurology 2010 225 1 24 28 2-s2.0-77955661661 10.1016/j.expneurol.2009.04.024
34. Boche D., Perry V. H., Nicoll J. A., Review: activation patterns of microGlia and their identification in the human brain. Neuropathology and Applied Neurobiology 2013 39 3 18
35. Nagele R. G., D'Andrea M. R., Lee H., Venkataraman V., Wang H. Y., Astrocytes accumulate A β 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Research 2003 971 2 197 209 2-s2.0-0037427384 10.1016/S0006-8993(03)02361-8 (Pubitemid 36423321)
36. Smits H. A., Rijsmus A., Van Loon J. H., Wat J. W. Y., Verhoef J., Boven L. A., Nottet H. S. L. M., Amyloid- β -induced chemokine production in primary human macrophages and astrocytes. Journal of Neuroimmunology 2002 127 1-2 160 168 2-s2.0-0036277146 10.1016/S0165-5728(02)00112-1 (Pubitemid 34603587)
37. Hashioka S., Klegeris A., Schwab C., McGeer P. L., Interferon- γ -dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiology of Aging 2009 30 12 1924 1935 2-s2.0-70349860184 10.1016/j.neurobiolaging.2008.02.019
38. Fuller S., Steele M., Münch G., Activated astroGlia during chronic inflammation in Alzheimer's disease-do they neglect their neurosupportive roles? Mutation Research 2010 690 1-2 40 49 2-s2.0-77955281765 10.1016/j.mrfmmm.2009. 08.016
39. Heneka M. T., O'Banion M. K., Terwel D., Kummer M. P., Neuroinflammatory processes in Alzheimer's disease. Journal of Neural Transmission 2010 117 8 919 947 2-s2.0-77956961694 10.1007/s00702-010-0438-z
40. Benzing W. C., Wujek J. R., Ward E. K., Shaffer D., Ashe K. H., Younkin S. G., Brunden K. R., Evidence for Glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiology of Aging 1999 20 6 581 589 2-s2.0-0033370498 10.1016/S0197-4580(99)00065-2 (Pubitemid 30064403)
41. White J. A., Manelli A. M., Holmberg K. H., van Eldik L. J., LaDu M. J., Differential effects of oligomeric and fibrillar amyloid- β 1-42 on astrocyte-mediated inflammation. Neurobiology of Disease 2005 18 3 459 465 2-s2.0-14744283139 10.1016/j.nbd.2004.12.013 (Pubitemid 40332705)
42. Fioravanzo L., Venturini M., Di Liddo R., Involvement of rat hippocampal astrocytes in beta-amyloid-induced angiogenesis and neuroinflammation. Current Alzheimer Research 2010 7 591 601
43. Abramov A. Y., Canevari L., Duchen M. R., Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. The Journal of Neuroscience 2003 23 12 5088 5095 2-s2.0-0038452658 (Pubitemid 36793236)
44. Allaman I., Gavillet M., Bélanger M., Laroche T., Viertl D., Lashuel H. A., Magistretti P. J., Amyloid- β aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. The Journal of Neuroscience 2010 30 9 3326 3338 2-s2.0-77749336627 10.1523/JNEUROSCI.5098-09. 2010
45. Gavillet M., Allaman I., Magistretti P. J., Modulation of astrocytic metabolic phenotype by proinflammatory cytokines. Glia 2008 56 9 975 989 2-s2.0-51349122248 10.1002/Glia.20671
46. Furman J. L., Sama D. M., Gant J. C., Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. The Journal of Neuroscience 2012 32 16129 16140
47. von Bernhardi R., Eugenín J., MicroGlial reactivity to β -amyloid is modulated by astrocytes and proinflammatory factors. Brain Research 2004 1025 1-2 186 193 2-s2.0-5344277492 10.1016/j.brainres.2004.07.084 (Pubitemid 39349537)
48. Ramírez G., Toro R., Döbeli H., von Bernhardi R., Protection of rat primary hippocampal cultures from A β cytotoxicity by pro-inflammatory molecules is mediated by astrocytes. Neurobiology of Disease 2005 19 1-2 243 254 2-s2.0-17444387480 10.1016/j.nbd.2005.01.007 (Pubitemid 40544742)
49. Alarcón R., Fuenzalida C., Santibáñez M., von Bernhardi R., Expression of scavenger receptors in Glial cells: comparing the adhesion of astrocytes and microGlia from neonatal rats to surface-bound β -amyloid. The Journal of Biological Chemistry 2005 280 34 30406 30415 2-s2.0-24044503374 10.1074/jbc.M414686200 (Pubitemid 41216224)
50. Chang Z. L., Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflammation Research 2010 59 10 791 808 2-s2.0-77956929099 10.1007/s00011-010-0208-2
51. Ricevuti G., Mazzone A., Fossati G., Mazzucchelli I., CaviGliano P. M., Pasotti D., Notario A., Assay of phagocytic cell functions. Allergie et Immunologie 1993 25 2 55 60 2-s2.0-0027314942
52. Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S., Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proceedings of the National Academy of Sciences of the United States of America 1979 76 1 333 337 2-s2.0-0009627006 (Pubitemid 9110191)
53. Hickman S. E., Allison E. K., El Khoury J., MicroGlial dysfunction and defective β -amyloid clearance pathways in aging Alzheimer's disease mice. The Journal of Neuroscience 2008 28 33 8354 8360 2-s2.0-51149120624 10.1523/JNEUROSCI.0616-08.2008
54. Wilkinson K., El Khoury J., MicroGlial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease. International Journal of Alzheimer's Disease 2012 2012 10 489456 10.1155/2012/489456
55. Arai T., Rinninger F., Varban L., Fairchild-Huntress V., Liang C. P., Chen W., Seo T., Deckelbaum R., Huszar D., Tall A. R., Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proceedings of the National Academy of Sciences of the United States of America 1999 96 21 12050 12055 2-s2.0-13044270401 10.1073/pnas.96.21. 12050 (Pubitemid 29502856)
56. Krieger M., Kozarsky K., Influence of the HDL receptor SR-BI on atherosclerosis. Current Opinion in Lipidology 1999 10 6 491 497 2-s2.0-0033383564 10.1097/00041433-199912000-00003 (Pubitemid 30064018)
57. Husemann J., Silverstein S. C., Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain. American Journal of Pathology 2001 158 3 825 832 2-s2.0-0035101055 (Pubitemid 32221775)
58. Baranova I. N., Vishnyakova T. G., Bocharov A. V., Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60. The Journal of Immunology 2012 188 1371 1380
59. Buechler C., Ritter M., Quoc C. D., Agildere A., Schmitz G., Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages. Biochemical and Biophysical Research Communications 1999 262 1 251 254 2-s2.0-0033584409 10.1006/bbrc.1999.1193 (Pubitemid 29412655)
60. Guo L., Song Z., Li M., Wu Q., Wang D., Feng H., Bernard P., Daugherty A., Huang B., Li X. A., Scavenger receptor BI protects against septic death through its role in modulating inflammatory response. The Journal of Biological Chemistry 2009 284 30 19826 19834 2-s2.0-67749113649 10.1074/jbc.M109.020933
61. Cai L., Wang Z., Meyer J. M., Ji A., van der Westhuyzen D. R., Macrophage SR-BI regulates LPS-induced pro-inflammatory signaling in mice and isolated macrophages. The Journal of Lipid Research 2012 53 1472 1481
62. Chang G. H. F., Barbaro N. M., Pieper R. O., Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microGlia, astrocytes, and glioma cells. Neuro-Oncology 2000 2 3 174 183 2-s2.0-0034231922
63. Husemann J., Loike J. D., Kodama T., Silverstein S. C., Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microGlia to fibrillar β -amyloid. Journal of Neuroimmunology 2001 114 1-2 142 150 2-s2.0-0035283232 10.1016/S0165-5728(01)00239-9 (Pubitemid 32184735)
64. Thanopoulou K., Fragkouli A., Stylianopoulou F., Georgopoulos S., Scavenger receptor class B type i (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model. Proceedings of the National Academy of Sciences of the United States of America 2010 107 48 20816 20821 2-s2.0-78650527026 10.1073/pnas.1005888107
65. Febbraio M., Hajjar D. P., Silverstein R. L., CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. The Journal of Clinical Investigation 2001 108 6 785 791 2-s2.0-0034833822 10.1172/JCI200114006 (Pubitemid 32880285)
66. Hwang E. H., Taki J., Yasue S., Fujimoto M., Taniguchi M., Matsunari I., Nakajima K., Shiobara S., Ikeda T., Tonami N., Absent myocardial iodine-123-BMIPP uptake and platelet/monocyte CD36 deficiency. Journal of Nuclear Medicine 1998 39 10 1681 1684 2-s2.0-0031714738 (Pubitemid 28473512)
67. Savill J., Hogg N., Ren Y., Haslett C., Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. The Journal of Clinical Investigation 1992 90 4 1513 1522 2-s2.0-0026453281
68. Barnwell J. W., Asch A. S., Nachman R. L., Yamaya M., Aikawa M., Ingravallo P., A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum -infected erythrocytes. The Journal of Clinical Investigation 1989 84 3 765 772 2-s2.0-0024417163 (Pubitemid 19228345)
69. Bao Y., Qin L., Kim E., CD36 is involved in astrocyte activation and astroGlial scar formation. Journal of Cerebral Blood Flow and Metabolism 2012 32 1567 1577
70. Coraci I. S., Husemann J., Berman J. W., Hulette C., Dufour J. H., Campanella G. K., Luster A. D., Silverstein S. C., El Khoury J. B., CD36, a class B scavenger receptor, is expressed on microGlia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β -amyloid fibrils. American Journal of Pathology 2002 160 1 101 112 2-s2.0-0036141148 (Pubitemid 34052271)
71. Stuart L. M., Bell S. A., Stewart C. R., Silver J. M., Richard J., Goss J. L., Tseng A. A., Zhang A., El Khoury J. B., Moore K. J., CD36 signals to the actin cytoskeleton and regulates microGlial migration via a p130Cas complex. The Journal of Biological Chemistry 2007 282 37 27392 27401 2-s2.0-34848909318 10.1074/jbc.M702887200 (Pubitemid 47501980)
72. Cho S., Park E. M., Febbraio M., Anrather J., Park L., Racchumi G., Silverstein R. L., Iadecola C., The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. The Journal of Neuroscience 2005 25 10 2504 2512 2-s2.0-14944379101 10.1523/JNEUROSCI.0035-05. 2005 (Pubitemid 40365160)
73. Kunz A., Abe T., Hochrainer K., Shimamura M., Anrather J., Racchumi G., Zhou P., Iadecola C., Nuclear factor- B activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion. The Journal of Neuroscience 2008 28 7 1649 1658 2-s2.0-39549117568 10.1523/JNEUROSCI.5205-07.2008 (Pubitemid 351287045)
74. Moore K. J., El Khoury J., Medeiros L. A., Terada K., Geula C., Luster A. D., Freeman M. W., A CD36-initiated signaling cascade mediates inflammatory effects of β -amyloid. The Journal of Biological Chemistry 2002 277 49 47373 47379 2-s2.0-0346003785 10.1074/jbc.M208788200 (Pubitemid 36163374)
75. Bamberger M. E., Harris M. E., McDonald D. R., Husemann J., Landreth G. E., A cell surface receptor complex for fibrillar β -amyloid mediates microGlial activation. The Journal of Neuroscience 2003 23 7 2665 2674 2-s2.0-0037387147 (Pubitemid 36418601)
76. El Khoury J. B., Moore K. J., Means T. K., Leung J., Terada K., Toft M., Freeman M. W., Luster A. D., CD36 mediates the innate host response to β -amyloid. Journal of Experimental Medicine 2003 197 12 1657 1666 2-s2.0-0038204838 10.1084/jem.20021546 (Pubitemid 36745341)
77. Ricciarelli R., D'Abramo C., Zingg J. M., Giliberto L., Markesbery W., Azzi A., Marinari U. M., Pronzato M. A., Tabaton M., CD36 overexpression in human brain correlates with β -amyloid deposition but not with Alzheimer's disease. Free Radical Biology and Medicine 2004 36 8 1018 1024 2-s2.0-1642603878 10.1016/j.freeradbiomed.2004.01.007 (Pubitemid 38410808)
78. Giunta M., Rigamonti A. E., Scarpini E., Galimberti D., Bonomo S. M., Venturelli E., Müller E. E., Cella S. G., The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging 2007 28 4 515 518 2-s2.0-33847204688 10.1016/j. neurobiolaging.2006.02.002
79. Park L., Zhou J., Zhou P., Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proceedings of the National Academy of Sciences of the United States of America 2013 10.1073/pnas.1300021110
80. Shimizu E., Kawahara K., Kajizono M., Sawada M., Nakayama H., IL-4-induced selective clearance of oligomeric β -amyloid peptide 1-42 by rat primary type 2 microGlia. The Journal of Immunology 2008 181 9 6503 6513 2-s2.0-58749093072
81. Jones R. S., Minogue A. M., Connor T. J., Lynch M. A., Amyloid-beta-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE. Journal of Neuroimmune Pharmacology 2012 8 1 301 311
82. Park L., Wang G., Zhou P., Zhou J., Pitstick R., Previti M. L., Younkin L., Younkin S. G., Van Nostrand W. E., Cho S., Anrather J., Carlson G. A., Iadecola C., Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid- β Proceedings of the National Academy of Sciences of the United States of America 2011 108 12 5063 5068 2-s2.0-79953213351 10.1073/pnas.1015413108
83. Neeper M., Schmidt A. M., Brett J., Shi Du Yan, Wang F., Pan Y. C. E., Elliston K., Stern D., Shaw A., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. The Journal of Biological Chemistry 1992 267 21 14998 15004 2-s2.0-0026659883
84. Brett J., Schmidt A. M., Yan S. D., Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. American Journal of Pathology 1993 143 6 1699 1712 2-s2.0-0027718105 (Pubitemid 24058273)
85. Taguchi A., Blood D. C., Del Toro G., Canet A., Lee D. C., Qu W., Tanjl N., Lu Y., Lalla E., Fu C., Hofmann M. A., Kislinger T., Ingram M., Lu A., Tanaka H., Hori O., Ogawa S., Stern D. M., Schmidt A. M., Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000 405 6784 354 360 2-s2.0-0034682315 10.1038/35012626 (Pubitemid 30337069)
86. Yan S. D., Schmidt A. M., Anderson G. M., Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. The Journal of Biological Chemistry 1994 269 13 9889 9897 2-s2.0-0028304625 (Pubitemid 24196599)
87. Andrassy M., Igwe J., Autschbach F., Volz C., Remppis A., Neurath M. F., Schleicher E., Humpert P. M., Wendt T., Liliensiek B., Morcos M., Schiekofer S., Thiele K., Chen J., Kientsch-Engel R., Schmidt A. M., Stremmel W., Stern D. M., Katus H. A., Nawroth P. P., Bierhaus A., Posttranslationally modified proteins as mediators of sustained intestinal inflammation. American Journal of Pathology 2006 169 4 1223 1237 2-s2.0-33847296039 10.2353/ajpath.2006.050713 (Pubitemid 351194359)
88. Giri R., Shen Y., Stins M., Yan S. D., Schmidt A. M., Stern D., Kim K. S., Zlokovic B., Kalra V. K., β -Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. American Journal of Physiology 2000 279 6 C1772 C1781 2-s2.0-0033639245
89. Arancio O., Zhang H. P., Chen X., Lin C., Trinchese F., Puzzo D., Liu S., Hegde A., Yan S. F., Stern A., Luddy J. S., Lue L. F., Walker D. G., Roher A., Buttini M., Mucke L., Li W., Schmidt A. M., Kindy M., Hyslop P. A., Stern D. M., Yan S. S. D., RAGE potentiates A β -induced perturbation of neuronal function in transgenic mice. The EMBO Journal 2004 23 20 4096 4105 2-s2.0-8144223671 10.1038/sj.emboj.7600415 (Pubitemid 39472430)
90. OriGlia N., Bonadonna C., Rosellini A., Leznik E., Arancio O., Yan S. S., Domenici L., MicroGlial receptor for advanced glycation end product-dependent signal pathway drives β -amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex. The Journal of Neuroscience 2010 30 34 11414 11425 2-s2.0-77956104594 10.1523/JNEUROSCI.2127-10.2010
91. Vodopivec I., Galichet A., Knobloch M., Bierhaus A., Heizmann C. W., Nitsch R. M., RAGE does not affect amyloid pathology in transgenic arcA β mice. Neurodegenerative Diseases 2009 6 5-6 270 280 2-s2.0-77949373109 10.1159/000261723
92. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., Krieger M., Type I macrophage scavenger receptor contains α -helical and collagen-like coiled coils. Nature 1990 343 6258 531 535 2-s2.0-0025177343 10.1038/343531a0 (Pubitemid 20042711)
93. Rohrer L., Freeman M., Kodama T., Penman M., Krieger M., Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 1990 343 6258 570 572 2-s2.0-0025061077 10.1038/343570a0 (Pubitemid 20042720)
94. Matsumoto A., Naito M., Itakura H., Ikemoto S., Asaoka H., Hayakawa I., Kanamori H., Aburatani H., Takaku F., Suzuki H., Kobari Y., Miyai T., Takahashi K., Cohen E. H., Wydro R., Housman D. E., Kodama T., Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America 1990 87 23 9133 9137 2-s2.0-0025612173 10.1073/pnas.87.23.9133 (Pubitemid 120030579)
95. El Khoury J., Thomas C. A., Loike J. D., Hickman S. E., Cao L., Silverstein S. C., Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. The Journal of Biological Chemistry 1994 269 14 10197 10200 2-s2.0-0028364606 (Pubitemid 24198204)
96. Hampton R. Y., Golenbock D. T., Penman M., Krieger M., Raetz C. R. H., Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991 352 6333 342 344 2-s2.0-0025874032 10.1038/352342a0 (Pubitemid 21912355)
97. Thomas C. A., Li Y., Kodama T., Suzuki H., Silverstein S. C., El Khoury J., Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. Journal of Experimental Medicine 2000 191 1 147 156 2-s2.0-0034598314 10.1084/jem.191.1.147 (Pubitemid 30043656)
98. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Horiuchi S., Takahashi K., Kruijt J. K., Van Berkel T. J. C., Steinbrecher U. P., Ishibashi S., Maeda N., Gordon S., Kodama T., A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997 386 6622 292 296 2-s2.0-0030895048 10.1038/386292a0 (Pubitemid 27142516)
99. Kobayashi Y., Miyaji C., Watanabe H., Umezu H., Hasegawa G., Abo T., Arakawa M., Kamata N., Suzuki H., Kodama T., Naito M., Role of macrophage scavenger receptor in endotoxin shock. Journal of Pathology 2000 192 2 263 272 2-s2.0-0033780863
100. Yi H., Yu X., Gao P., Wang Y., Baek S. H., Chen X., Kim H. L., Subjeck J. R., Wang X. Y., Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation. Blood 2009 113 23 5819 5828 2-s2.0-67651115866 10.1182/blood-2008-11-190033
101. Chen Y., Wermeling F., Sundqvist J., Jonsson A. B., Tryggvason K., Pikkarainen T., Karlsson M. C. I., A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses. European Journal of Immunology 2010 40 5 1451 1460 2-s2.0-77951710075 10.1002/eji.200939891
102. Ohnishi K., Komohara Y., Fujiwara Y., Takemura K., Lei X., Nakagawa T., Sakashita N., Takeya M., Suppression of TLR4-mediated inflammatory response by macrophage class A scavenger receptor (CD204). Biochemical and Biophysical Research Communications 2011 411 3 516 522 2-s2.0-79961128535 10.1016/j.bbrc.2011.06.161
103. Yu X., Yi H., Guo C., Zuo D., Wang Y., Kim H. L., Subjeck J. R., Wang X. Y., Pattern recognition scavenger receptor CD204 attenuates toll-like receptor 4-induced NF- B activation by directly inhibiting ubiquitination of Tumor Necrosis Factor (TNF) receptor-associated factor 6. The Journal of Biological Chemistry 2011 286 21 18795 18806 2-s2.0-79956303064 10.1074/jbc.M111.224345
104. Yu H., Ha T., Liu L., Scavenger receptor A, (SR-A) is required for LPS-induced TLR4 mediated NF-kappaB activation in macrophages. Biochimica et Biophysica Acta 2012 1823 1192 1198
105. Fadok V. A., Voelker D. R., Campbell P. A., Cohen J. J., Bratton D. L., Henson P. M., Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. The Journal of Immunology 1992 148 7 2207 2216 2-s2.0-0026508561
106. Platt N., Suzuki H., Kurihara Y., Kodama T., Gordon S., Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proceedings of the National Academy of Sciences of the United States of America 1996 93 22 12456 12460 2-s2.0-0029960471 10.1073/pnas.93.22.12456 (Pubitemid 26367165)
107. Hu Y., Zhang H., Lu Y., Bai H., Xu Y., Zhu X., Zhou R., Ben J., Xu Y., Chen Q., Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization. Basic Research in Cardiology 2012 106 1311 1328 2-s2.0-79960336628 10.1007/s00395-011-0204-x
108. Nikolic D., Calderon L., Du L., Post S. R., SR-A ligand and M-CSF dynamically regulate SR-A expression and function in primary macrophages via p38 MAPK activation. BMC Immunology 2011 12, article 37 2-s2.0-79959948211 10.1186/1471-2172-12-37
109. Cholewa J., Nikolic D., Post S. R., Regulation of class a scavenger receptor-mediated cell adhesion and surface localization by PI3K: identification of a regulatory cytoplasmic motif. Journal of Leukocyte Biology 2010 87 3 443 449 2-s2.0-77950359880 10.1189/jlb.0509318
110. Bell M. D., Lopez-Gonzalez R., Lawson L., Hughes D., Fraser I., Gordon S., Perry V. H., Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. Journal of Neurocytology 1994 23 10 605 613 2-s2.0-0028019733 10.1007/BF01191555 (Pubitemid 24375921)
111. Christie R. H., Freeman M., Hyman B. T., Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microGlia associated with senile plaques in Alzheimer's disease. American Journal of Pathology 1996 148 2 399 403 2-s2.0-0030039871 (Pubitemid 26056725)
112. Lucarelli M., Gennarelli M., Cardelli P., Novelli G., Scarpa S., Dallapiccola B., Strom R., Expression of receptors for native and chemically modified low-density lipoproteins in brain microvessels. FEBS Letters 1997 401 1 53 58 2-s2.0-0031016109 10.1016/S0014-5793(96)01435-4 (Pubitemid 27051257)
113. Grewal R. P., Yoshida T., Finch C. E., Morgan T. E., Scavenger receptor mRNAs in rat brain microGlia are induced by kainic acid lesioning and by cytokines. NeuroReport 1997 8 5 1077 1081 2-s2.0-0030954050 (Pubitemid 27198572)
114. Honda M., Akiyama H., Yamada Y., Kondo H., Kawabe Y., Takeya M., Takahashi K., Suzuki H., Doi T., Sakamoto A., Ookawara S., Mato M., Gough P. J., Greaves D. R., Gordon S., Kodama T., Matsushita M., Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microGlia of ischemia and Alzheimer's disease. Biochemical and Biophysical Research Communications 1998 245 3 734 740 2-s2.0-0032576963 10.1006/bbrc.1998.8120 (Pubitemid 28413987)
115. Godoy B., Murgas P., Tichauer J., von Bernhardi R., Scavenger receptor class A ligands induce secretion of IL1beta and exert a modulatory effect on the inflammatory activation of astrocytes in culture. Journal of Neuroimmunology 2012 251 6 13
116. Lu C., Hua F., Liu L., Ha T., Kalbfleisch J., Schweitzer J., Kelley J., Kao R., Williams D., Li C., Scavenger receptor class-A has a central role in cerebral ischemia-reperfusion injury. Journal of Cerebral Blood Flow and Metabolism 2010 30 12 1972 1981 2-s2.0-78649693179 10.1038/jcbfm.2010.59
117. Xu Y., Qian L., Zong G., Class A scavenger receptor promotes cerebral ischemic injury by pivoting microGlia/macrophage polarization. Neuroscience 2012 218 35 48
118. Ren D., Wang X., Ha T., SR-A deficiency reduces myocardial ischemia/reperfusion injury, involvement of increased microRNA-125b expression in macrophages. Biochimica et Biophysica Acta 2013 1832 336 346
119. Bornemann K. D., Wiederhold K. H., Pauli C., Ermini F., Stalder M., Schnell L., Sommer B., Jucker M., Staufenbiel M., A β -induced inflammatory processes in microGlia cells of APP23 transgenic mice. American Journal of Pathology 2001 158 1 63 73 2-s2.0-0034746387 (Pubitemid 32096472)
120. El Khoury J., Hickman S. E., Thomas C. A., Cao L., Silverstein S. C., Loike J. D., Scavenger receptor-mediated adhesion of microGlia to β -amyloid fibrils. Nature 1996 382 6593 716 719 2-s2.0-0029787599 10.1038/382716a0 (Pubitemid 26282177)
121. Prior R., Wihl G., Urmoneit B., Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential pole of impaired cerebrovascular A β clearance. Annals of the New York Academy of Sciences 2000 903 180 186 2-s2.0-0034016989 (Pubitemid 30251557)
122. Chung H., Brazil M. I., Irizarry M. C., Hyman B. T., Maxfield F. R., Uptake of fibrillar β -amyloid by microGlia isolated from MSR-A (type I and type II) knockout mice. NeuroReport 2001 12 6 1151 1154 2-s2.0-0035826957 (Pubitemid 32374734)
123. Yang C. N., Shiao Y. J., Shie F. S., Mechanism mediating oligomeric Abeta clearance by naive primary microGlia. Neurobiology of Disease 2011 42 221 230
124. Elomaa O., Kangas M., Sahlberg C., Tuukkanen J., Sormunen R., Liakka A., Thesleff I., Kraal G., Tryggvason K., Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995 80 4 603 609 2-s2.0-0028927709
125. van der Laan L. J. W., Kangas M., Döpp E. A., Broug-Holub E., Elomaa O., Tryggvason K., Kraal G., Macrophage scavenger receptor marco: in vitro and in vivo regulation and involvement in the anti-bacterial host defense. Immunology Letters 1997 57 1-3 203 208 2-s2.0-0030813871 10.1016/S0165-2478(97) 00077-1 (Pubitemid 27319339)
126. van der Laan L. J. W., Döpp E. A., Haworth R., Pikkarainen T., Kangas M., Elomaa O., Dijkstra C. D., Gordon S., Tryggvason K., Kraal G., Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. The Journal of Immunology 1999 162 2 939 947 2-s2.0-0344428149 (Pubitemid 29035419)
127. Pikkarainen T., Brännström A., Tryggvason K., Expression of macrophage MARCO receptor induces formation of dendritic plasma membrane processes. The Journal of Biological Chemistry 1999 274 16 10975 10982 2-s2.0-0344938124 10.1074/jbc.274.16.10975 (Pubitemid 29191083)
128. Granucci F., Petralia F., Urbano M., Citterio S., Di Tota F., Santambrogio L., Ricciardi-Castagnoli P., The scavenger receptor MARCO mediates cytoskeleton rearrangements in dendritic cells and microGlia. Blood 2003 102 8 2940 2947 2-s2.0-0141923860 10.1182/blood-2002-12-3651 (Pubitemid 37248868)
129. Martinez-Pomares L., Platt N., Mcknight A. J., Da Silva R. P., Gordon S., Macrophage membrane molecules: markers of tissue differentiation and heterogeneity. Immunobiology 1996 195 4-5 407 416 2-s2.0-0029836961 (Pubitemid 26361473)
130. Argiles A., Mourad G., Kerr P. G., Garcia M., Collins B., Demaille J. G., Cells surrounding haemodialysis-associated amyloid deposits are mainly macrophages. Nephrology Dialysis Transplantation 1994 9 6 662 667 2-s2.0-0028358599 (Pubitemid 24192953)
131. Yoshida H., Kondratenko N., Green S., Steinberg D., Quehenberger O., Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochemical Journal 1998 334, part 1 9 13 2-s2.0-0032528913 (Pubitemid 28420964)
132. Luedecking-Zimmer E., DeKosky S. T., Chen Q., Barmada M. M., Kamboh M. I., Investigation of oxidized LDL-receptor 1 (ORL1) as the candidate gene for Alzheimer's disease on chromosome 12. Human Genetics 2002 111 4-5 443 451 2-s2.0-0036820942 10.1007/s00439-002-0802-7 (Pubitemid 36075074)
133. Shi J., Tian J., Pritchard A., Lendon C., Lambert J. C., Iwatsubo T., Mann D. M. A., A 3'-UTR polymorphism in the oxidized LDL receptor 1 gene increases A β 40 load as cerebral amyloid angiopathy in Alzheimer's disease. Acta Neuropathologica 2006 111 1 15 20 2-s2.0-29544439106 10.1007/s00401-005-1108-3 (Pubitemid 43013822)
134. Suzuki E., Nakayama M., The mammalian Ced-1 ortholog MEGF10/KIAA1780 displays a novel adhesion pattern. Experimental Cell Research 2007 313 11 2451 2464 2-s2.0-34249987983 10.1016/j.yexcr.2007.03.041 (Pubitemid 46891475)
135. Singh T. D., Park S. Y., Bae J. S., Yun Y., Bae Y. C., Park R. W., Kim I. S., MEGF10 functions as a receptor for the uptake of amyloid- β FEBS Letters 2010 584 18 3936 3942 2-s2.0-77956898818 10.1016/j.febslet.2010.08.050